You need to create a user account to read this article.
With a subscription you unlock more content on BioStock.
Sound Bioventures invests SEK 34 million in Boost Pharma
Text:
Kim Liedholm | [email protected]
Danish cell therapy company Boost Pharma has secured SEK 34 million in new capital from Nordic venture capital firm Sound Bioventures. The investment will support the continued development of the company's lead candidate BT-101,...